![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Review |
|---|---|
| Title: | Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies |
| Creators Name: | Frantz, S., Hundertmark, M.J., Schulz-Menger, J., Bengel, F.M. and Bauersachs, J. |
| Abstract: | Most patients survive acute myocardial infarction (MI). Yet this encouraging development has certain drawbacks: heart failure (HF) prevalence is increasing and patients affected tend to have more comorbidities worsening economic strain on healthcare systems and impeding effective medical management. The heart's pathological changes in structure and/or function, termed myocardial remodelling, significantly impact on patient outcomes. Risk factors like diabetes, chronic obstructive pulmonary disease, female sex, and others distinctly shape disease progression on the 'road to HF'. Despite the availability of HF drugs that interact with general pathways involved in myocardial remodelling, targeted drugs remain absent, and patient risk stratification is poor. Hence, in this review, we highlight the pathophysiological basis, current diagnostic methods and available treatments for cardiac remodelling following MI. We further aim to provide a roadmap for developing improved risk stratification and novel medical and interventional therapies. |
| Keywords: | Remodelling, Fibrosis, Heart Failure, Myocardial Infarction |
| Source: | European Heart Journal |
| ISSN: | 0195-668X |
| Publisher: | Oxford University Press |
| Volume: | 43 |
| Number: | 27 |
| Page Range: | 2549-2561 |
| Date: | 14 July 2022 |
| Official Publication: | https://doi.org/10.1093/eurheartj/ehac223 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
